AVM
Arch Venture Management Portfolio holdings
AUM $299M
1-Year Return
19.47%
This Quarter Return
-27.39%
1 Year Return
-19.47%
3 Year Return
-31.35%
5 Year Return
–
10 Year Return
–
AUM
$206M
AUM Growth
-$24M
(-10%)
Cap. Flow
+$42.8M
Cap. Flow
% of AUM
20.78%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
–
Reduced
1
Closed
1
Top Buys
| 1 |
MAZE
Maze Therapeutics, Inc. Common Stock
MAZE
|
+$45.4M |
Top Sells
| 1 |
OMIC
Singular Genomics Systems, Inc. Common Stock
OMIC
|
+$2.46M |
| 2 |
CERo Therapeutics
CERO
|
+$52.4K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Beam Therapeutics
BEAM
$2.11B
| $88.7M | 43% |
4,540,132
| – | – |
|
|
MAZE
2
Maze Therapeutics, Inc. Common Stock
MAZE
$987M
| $45.4M | 22% |
+4,120,053
| New | +$45.4M |
|
|
RAPP
3
Rapport Therapeutics
RAPP
$1.09B
| $37.5M | 18.21% |
3,728,738
| – | – |
|
4
Erasca
ERAS
$440M
| $15.1M | 7.34% |
11,055,554
| – | – |
|
|
VERV
5
DELISTED
Verve Therapeutics
VERV
| $9.12M | 4.42% |
2,008,809
| – | – |
|
6
Gossamer Bio
GOSS
$750M
| $8.78M | 4.26% |
8,055,916
| – | – |
|
|
UBX
7
DELISTED
Unity Biotechnology
UBX
| $1.05M | 0.51% |
1,004,817
| – | – |
|
8
Q32 Bio
QTTB
$22.3M
| $532K | 0.26% |
320,482
| – | – |
|
|
9
CERo Therapeutics
CERO
$6.42M
| $16.1K | 0.01% |
1,105
-3,592
| -76% | -$52.4K |
|
|
OMIC
10
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
| – | – |
-126,630
| Closed | -$2.46M |
|